ShrujalSubhashBaxiMDMPH

Oncology • New York, NY

Head & Neck Cancer, Hematologic Oncology

Clinical Instructor at Memorial Sloan-Kettering Cancer Center

Join to view full profile

Dr. Baxi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Baxi's full profile

Already have an account?

Office
1275 York Ave
New York, NY 10065
Phone+1 212-639-2000

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
NYU Grossman School of MedicineResidency, Internal Medicine, 2004 - 2008
University of Illinois College of MedicineClass of 2004

Certifications & Licensure

FL State Medical License 2021 - Present
NJ State Medical License 2023 - 2025
NY State Medical License 2006 - 2025
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma.
Antoine Desilets, Joris L Vos, Nora Katabi, Fengshen Kuo, Zaineb Nadeem
Clinical Cancer Research. 2024-12-02
3 citations
Inter- and Intraobserver Variability on Endoscopic Scoring Systems in Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis.
Jana G Hashash, Faye Yu Ci Ng, Francis A Farraye, Yeli Wang, Daniel R Colucci
Inflammatory Bowel Diseases. 2024-11-04
1 citations
Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinoma.
Tanguy Y Seiwert, Sophie Wildsmith, Jérôme Fayette, Kevin Harrington, Maura Gillison
Cancer Immunology, Immunotherapy. 2024-03-02

Press Mentions

Lessons from Oncology – How We Can Better Utilize AI for GIJune 10th, 2023